Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Free Cash Flow (2018 - 2025)

Historic Free Cash Flow for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $66.8 million.

  • AdaptHealth's Free Cash Flow fell 2124.36% to $66.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $213.2 million, marking a year-over-year decrease of 704.24%. This contributed to the annual value of $235.8 million for FY2024, which is 6465.02% up from last year.
  • As of Q3 2025, AdaptHealth's Free Cash Flow stood at $66.8 million, which was down 2124.36% from $73.3 million recorded in Q2 2025.
  • In the past 5 years, AdaptHealth's Free Cash Flow registered a high of $116.7 million during Q2 2024, and its lowest value of -$46.0 million during Q4 2022.
  • Over the past 5 years, AdaptHealth's median Free Cash Flow value was $26.3 million (recorded in 2022), while the average stood at $30.2 million.
  • As far as peak fluctuations go, AdaptHealth's Free Cash Flow crashed by 24831.84% in 2021, and later skyrocketed by 304672.42% in 2024.
  • AdaptHealth's Free Cash Flow (Quarter) stood at $37.3 million in 2021, then tumbled by 223.28% to -$46.0 million in 2022, then skyrocketed by 244.85% to $66.6 million in 2023, then grew by 9.7% to $73.1 million in 2024, then decreased by 8.56% to $66.8 million in 2025.
  • Its Free Cash Flow was $66.8 million in Q3 2025, compared to $73.3 million in Q2 2025 and -$58000.0 in Q1 2025.